Secretary Azar Highlights Recognition of HHS as Top Agency for Regulatory Reform

Washington, DC - Health and Human Services Secretary Alex Azar issued the following statement today regarding the Office of Management and Budget’s release of the Fall 2018 Unified Agenda:

President Donald J. Trump Announces Intent to Nominate Personnel to Key Administration Posts

Washington, DC - President Donald J. Trump today announced his intent to nominate the following individuals to key positions in his Administration:

Vice President Pence During Tour of Feed Mill Affected by Hurricane Michael

Bainbridge, Georgia - Remarks by Vice President Pence During Tour of Feed Mill Affected by Hurricane Michael:

Investigation leads to federal conviction, seizure of $500,000 worth of counterfeit goods

Providence, Rhode Island - After a recent multiagency intellectual property rights investigation resulted in federal convictions of two Rhode Island men on counterfeit goods trafficking charges and the seizure of more than $500,000 worth of counterfeit goods, special agents from U.S. Immigration and Customs Enforcement’s (ICE) Homeland Security Investigations (HSI) Providence went on to coordinate an extraordinary effort that brought about the donation of half of the seized items to a non-governmental organization for use in humanitarian relief efforts.

President Donald J. Trump Announces Intent to Nominate Individuals to Key Administration Posts

Washington, DC - President Donald J. Trump today announced his intent to nominate the following individual to a key position in his Administration:

Attorney General Becerra Joins Coalition Announcing Nationwide Settlement on CVS Health, Aetna Merger

Sacramento, California - Wednesday, California Attorney General Xavier Becerra, along with the U.S. Department of Justice (USDOJ) and a multistate coalition, announced a settlement in the CVS Health (CVS) and Aetna merger. The settlement requires Aetna to sell the Medicare Part D plans of 1.5 million people to their competitor, WellCare Health Plans, to ensure competition in the prescription drug benefit market for Medicare beneficiaries. In addition, Aetna is prohibited from selling any new Medicare Part D plans in 2020.